Forum: Breast Cancer Newsfeed
08-04-2013, 05:17 PM
|
|
Replies: 2
Views: 1,186
Again!
Private laboratory oncologists have been making this point for years...finally validated -- in the JCO, no less!
All of these marker studies (including Her2, ER, KRAS, EGFR mutations, OncotypeDx,...
|
|
Forum: Breast Cancer Newsfeed
08-04-2013, 05:15 PM
|
|
Replies: 2
Views: 1,186
Fatal Flaw
In this prospective study, genomic testing that was prognostic for response to anthracycline and taxane therapy in women with newly diagnosed invasive breast cancer was shown to have improved on...
|
